Antitumor action of two rhodium and ruthenium complexes in comparison with cis-diamminedichloroplatinum(II).
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000378:metabolism; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007413:Intestinal Mucosa / Q000187:drug effects; D007668:Kidney / Q000187:drug effects; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012238:Rhodium / Q000009:adverse effects / Q000627:therapeutic use*; D012428:Ruthenium / Q000009:adverse effects / Q000627:therapeutic use*; D013154:Spleen / Q000187:drug effects
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D009943:Organophosphorus Compounds; D012334:RNA, Neoplasm; D012428:Ruthenium; D012238:Rhodium; D002945:Cisplatin